observational research

News

Study finds weight returns more quickly in GLP-1 users

People who use drugs like GLP-1 agonists to lose weight regain it more quickly than those who use a conventional approach of diet and exercise.

News

ASCO 25: Can GLP-1 drugs reduce cancer risk?

A study has suggested the benefits of GLP-1 agonists could extend to a reduction in the risk of a slew of cancers associated with being overweight.

Patients

Unifying observational research with a next-generation virtu...

Observational research is core to drug development, helping researchers understand the natural history of diseases and the real-world impact of treatments on patients.

Study finds weight returns more quickly in GLP-1 users

ASCO 25: Can GLP-1 drugs reduce cancer risk?

Unifying observational research with a next-generation virtu...

ASCO 2026: Chinese firms take a front seat in oncology, with...

Discover a new era of healthcare panel engagement: Grounded ...

Editor's Picks